Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

EPA:COVH - Euronext Paris - Matif - FR0000060303 - REIT - Currency: EUR

22.2  +0.1 (+0.45%)

Fundamental Rating

4

Overall COVH gets a fundamental rating of 4 out of 10. We evaluated COVH against 42 industry peers in the Diversified REITs industry. There are concerns on the financial health of COVH while its profitability can be described as average. COVH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year COVH was profitable.
In the past year COVH had a positive cash flow from operations.
In multiple years COVH reported negative net income over the last 5 years.
Each year in the past 5 years COVH had a positive operating cash flow.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

With a decent Return On Assets value of 3.14%, COVH is doing good in the industry, outperforming 66.67% of the companies in the same industry.
COVH's Return On Equity of 6.54% is fine compared to the rest of the industry. COVH outperforms 69.05% of its industry peers.
The Return On Invested Capital of COVH (3.98%) is better than 69.05% of its industry peers.
COVH had an Average Return On Invested Capital over the past 3 years of 3.85%. This is in line with the industry average of 3.74%.
The 3 year average ROIC (3.85%) for COVH is below the current ROIC(3.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.14%
ROE 6.54%
ROIC 3.98%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

COVH's Profit Margin of 80.73% is amongst the best of the industry. COVH outperforms 85.71% of its industry peers.
In the last couple of years the Profit Margin of COVH has declined.
The Operating Margin of COVH (103.45%) is better than 97.62% of its industry peers.
In the last couple of years the Operating Margin of COVH has remained more or less at the same level.
With a Gross Margin value of 13.66%, COVH is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of COVH has declined.
Industry RankSector Rank
OM 103.45%
PM (TTM) 80.73%
GM 13.66%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3Y-31.67%
GM growth 5Y-15.65%
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

3

2. Health

2.1 Basic Checks

COVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for COVH remains at a similar level compared to 1 year ago.
The number of shares outstanding for COVH has been increased compared to 5 years ago.
The debt/assets ratio for COVH is higher compared to a year ago.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

COVH has an Altman-Z score of 0.97. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COVH (0.97) is comparable to the rest of the industry.
The Debt to FCF ratio of COVH is 14.45, which is on the high side as it means it would take COVH, 14.45 years of fcf income to pay off all of its debts.
COVH has a Debt to FCF ratio of 14.45. This is comparable to the rest of the industry: COVH outperforms 50.00% of its industry peers.
COVH has a Debt/Equity ratio of 0.74. This is a neutral value indicating COVH is somewhat dependend on debt financing.
COVH has a Debt to Equity ratio (0.74) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 14.45
Altman-Z 0.97
ROIC/WACC0.77
WACC5.18%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.06 indicates that COVH should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.06, COVH is doing good in the industry, outperforming 76.19% of the companies in the same industry.
A Quick Ratio of 1.06 indicates that COVH should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.06, COVH is doing good in the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2041.36% over the past year.
Measured over the past years, COVH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.16% on average per year.
Looking at the last year, COVH shows a small growth in Revenue. The Revenue has grown by 3.18% in the last year.
COVH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.29% yearly.
EPS 1Y (TTM)2041.36%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%223.86%
Revenue 1Y (TTM)3.18%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%2.25%

3.2 Future

Based on estimates for the next years, COVH will show a small growth in Earnings Per Share. The EPS will grow by 0.90% on average per year.
The Revenue is expected to grow by 0.55% on average over the next years.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.61, COVH is valued correctly.
COVH's Price/Earnings ratio is in line with the industry average.
COVH is valuated rather cheaply when we compare the Price/Earnings ratio to 28.78, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 12.73, which indicates a correct valuation of COVH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COVH is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, COVH is valued a bit cheaper.
Industry RankSector Rank
PE 14.61
Fwd PE 12.73
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

COVH's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, COVH is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 15.45
EV/EBITDA 17.4
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COVH does not grow enough to justify the current Price/Earnings ratio.
COVH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.85
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

COVH has a Yearly Dividend Yield of 6.79%, which is a nice return.
COVH's Dividend Yield is a higher than the industry average which is at 7.70.
COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 6.79%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years3
Div Non Decr Years3
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

85.75% of the earnings are spent on dividend by COVH. This is not a sustainable payout ratio.
DP85.75%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (4/25/2025, 7:00:00 PM)

22.2

+0.1 (+0.45%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-16 2025-04-16
Earnings (Next)07-21 2025-07-21
Inst Owners32.4%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.29B
Analysts82.86
Price Target18.67 (-15.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.79%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP85.75%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.61
Fwd PE 12.73
P/S 11.82
P/FCF 15.45
P/OCF 9.44
P/B 0.96
P/tB 1.06
EV/EBITDA 17.4
EPS(TTM)1.52
EY6.85%
EPS(NY)1.74
Fwd EY7.86%
FCF(TTM)1.44
FCFY6.47%
OCF(TTM)2.35
OCFY10.59%
SpS1.88
BVpS23.18
TBVpS20.98
PEG (NY)4.85
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.14%
ROE 6.54%
ROCE 4.5%
ROIC 3.98%
ROICexc 4.22%
ROICexgc 4.46%
OM 103.45%
PM (TTM) 80.73%
GM 13.66%
FCFM 76.53%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexcg growth 3Y33.75%
ROICexcg growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3Y-31.67%
GM growth 5Y-15.65%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 14.45
Debt/EBITDA 7.34
Cap/Depr 235.3%
Cap/Sales 48.63%
Interest Coverage 4.58
Cash Conversion 100.84%
Profit Quality 94.79%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 0.97
F-Score6
WACC5.18%
ROIC/WACC0.77
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2041.36%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%223.86%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.18%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%2.25%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.2%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.64%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y7.43%
OCF growth 3Y30.01%
OCF growth 5Y4.76%